Other concurrent condition(s)-Smoking Posts on Medivizor
Navigation Menu

Other concurrent condition(s)-Smoking Posts on Medivizor

Smoking cessation after a first cardiovascular event lowers the risk of a second event

Posted by on Jul 26, 2019 in Coronary artery disease | 0 comments

In a nutshell This study investigated the relationship between smoking and the risk of a second cardiovascular event (CVE). Researchers suggested that after a first CVE, smoking cessation (SC; quit smoking) lowers the risk of a second CVE.  Some background Cardiovascular events (CVEs) include stroke, heart attack or death due to damage to the...

Read More

Blood pressure targets in high risk patients

Posted by on Jul 8, 2013 in Hypertension | 0 comments

In a nutshell In this article, the latest clinical trials are reviewed in an attempt to conclude what is the optimal blood pressure target for patients of cardiovascular (CV) events, such as heart attack or stroke. Some background Hypertension is defined as blood pressure higher than 140/90 mmHg at rest. The higher value is called systolic (SBP),...

Read More

Two classes of drugs that reduce the likelihood of cardiovascular complications in patients at high risk of heart failure

Posted by on Jun 13, 2013 in Coronary artery disease | 0 comments

In a nutshell The present study evaluated the effect of two drug groups – Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) – on cardiovascular (CV)-related events (e.g. heart attacks, strokes), occurence of heart failure (HF) and death, in patients with normal heart...

Read More

Efficacy and Safety of Dapagliflozin (Forxiga) in Type 2 Diabetics Treated with High Doses of Insulin

Posted by on Feb 23, 2013 in Diabetes mellitus | 0 comments

In a nutshell This trial assessed the efficacy and safety of a new diabetes drug, Dapagliflozin (Forxiga). Results revealed that the drug helps control difficult cases of type 2 diabetes with only moderate side-effects. Some background Dapagliflozin is a drug recently approved by the European Medicines Agency for the treatment of diabetes. Its...

Read More